{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:03:19Z","timestamp":1791442999488,"version":"4.3.3"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T00:00:00Z","timestamp":1757721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,10]]},"DOI":"10.1093\/schbul\/sbaf163","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T11:55:38Z","timestamp":1755690938000},"source":"Crossref","is-referenced-by-count":7,"title":["Not So Hasty: The Effect of Tapering Speed on Relapse May Still Be Important"],"prefix":"10.1093","volume":"52","author":[{"given":"Mark Abie","family":"Horowitz","sequence":"first","affiliation":[{"name":"Department of Research and Development, Goodmayes Hospital, North East London Foundation Trust , 157 Barley Lane, Goodmayes, Ilford IG3 8XJ ,","place":["United Kingdom"]},{"name":"Institute of Pharmaceutical Science, Franklin-Wilkins Building, King\u2019s College London , 150 Stamford Street, London , SE1 9NH,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"O\u2019Neill","sequence":"additional","affiliation":[{"name":"Community Mental Health Team, Leeds and York Partnership NHS Foundation Trust , Leeds, St Marys Road, Leeds, LS7 3JX ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Berna","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Strasbourg, University Hospitals of Strasbourg , Inserm U1329, 67091 Strasbourg Cedex ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Taylor","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Science, Franklin-Wilkins Building, King\u2019s College London , 150 Stamford Street, London , SE1 9NH,","place":["United Kingdom"]},{"name":"Pharmacy Department, South London and Maudsley NHS Foundation Trust , London SE5 8AZ ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,13]]},"reference":[{"key":"2026062708162232300_ref1","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/wps.21315","article-title":"Risk of relapse during tapering of antipsychotic medication after a first psychotic episode: association with D2 receptor affinity but not with tapering speed","volume":"24","author":"Gangadin","year":"2025","journal-title":"World Psychiatry"},{"key":"2026062708162232300_ref2","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1093\/schbul\/sbab017","article-title":"A method for tapering antipsychotic treatment that may minimize the risk of relapse","volume":"47","author":"Horowitz","year":"2021","journal-title":"Schizophr Bull"},{"key":"2026062708162232300_ref3","volume-title":"The Maudsley Deprescribing Guidelines in Psychiatry: Antidepressants, Benzodiazepines, Gabapentinoids and Z-Drugs","author":"Horowitz","year":"2024"},{"key":"2026062708162232300_ref4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/schbul\/sbac138","article-title":"Risk factors for psychotic relapse after dose reduction or discontinuation of antipsychotics in patients with chronic schizophrenia. A meta-analysis of randomized controlled trials","volume":"49","author":"Bogers","year":"2023","journal-title":"Schizophr Bull"},{"key":"2026062708162232300_ref5","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/schbul\/sbab091","article-title":"Predictors of lack of relapse after random discontinuation of oral and long-acting injectable antipsychotics in clinically stabilized patients with schizophrenia: a re-analysis of individual participant data","volume":"48","author":"Schoretsanitis","year":"2021","journal-title":"Schizophr Bull"},{"key":"2026062708162232300_ref6","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/schbul\/sbad139","article-title":"Does slow and steady win the race? Rates of antipsychotic discontinuation, antipsychotic dose, and risk of psychotic relapse","volume":"50","author":"McCutcheon","year":"2023","journal-title":"Schizophr Bull"},{"key":"2026062708162232300_ref7","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S0140-6736(21)01997-8","article-title":"Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis","volume":"399","author":"Schneider-Thoma","year":"2022","journal-title":"Lancet"},{"key":"2026062708162232300_ref8","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1192\/bjp.157.4.585","article-title":"Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication","volume":"157","author":"Glazer","year":"1990","journal-title":"Br J Psychiatry"},{"key":"2026062708162232300_ref9","doi-asserted-by":"publisher","first-page":"7078","DOI":"10.1017\/S0033291723000429","article-title":"Guided antipsychotic reduction to reach minimum effective dose (GARMED) in patients with remitted psychosis: a 2-year randomized controlled trial with a naturalistic cohort","volume":"53","author":"Liu","year":"2023","journal-title":"Psychol Med"},{"key":"2026062708162232300_ref10","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1523\/JNEUROSCI.5416-06.2007","article-title":"\u201cBreakthrough\u201d dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over time","volume":"27","author":"Samaha","year":"2007","journal-title":"J Neurosci"},{"key":"2026062708162232300_ref11","volume-title":"A Prospective, Randomized, and Controlled Study Comparing Two Treatment Strategies (Dose REduction of Antipsychotics vs. Maintenance Treatment) in Patients With Schizophrenia Spectrum Disorder After Stratification Based on Patients\u2019 Psychotic PHENotype: A Personalized Medicine Approach","author":"Berna","year":"2020"}],"container-title":["Schizophrenia Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/52\/3\/sbaf163\/64262179\/sbaf163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/52\/3\/sbaf163\/64262179\/sbaf163.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T12:16:30Z","timestamp":1782562590000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article\/doi\/10.1093\/schbul\/sbaf163\/8253573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,13]]},"references-count":11,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9,13]]},"published-print":{"date-parts":[[2026,4,10]]}},"URL":"https:\/\/doi.org\/10.1093\/schbul\/sbaf163","relation":{},"ISSN":["0586-7614","1745-1701"],"issn-type":[{"value":"0586-7614","type":"print"},{"value":"1745-1701","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2025,9,13]]},"article-number":"sbaf163"}}